NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $125,000 | +278.8% | 123,545 | +261.8% | 0.00% | – |
Q4 2020 | $33,000 | -54.8% | 34,152 | -55.1% | 0.00% | – |
Q3 2020 | $73,000 | +711.1% | 76,128 | +907.0% | 0.00% | – |
Q2 2020 | $9,000 | +28.6% | 7,560 | 0.0% | 0.00% | – |
Q1 2020 | $7,000 | – | 7,560 | -100.0% | 0.00% | – |
Q1 2019 | $0 | – | 18,991,000 | +72.6% | 0.00% | – |
Q4 2018 | $0 | – | 11,000,000 | +606.0% | 0.00% | – |
Q3 2018 | $0 | – | 1,558,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |